A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
NEW YORK, Feb. 19, 2020 -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that Elizabeth Czerepak, a financial executive and board member with experience in pharma,...
FOCUS Top-line Results Expected Mid-2020NEW YORK, Jan. 13, 2020 -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today announced it has completed patient enrollment...
NEW YORK, Dec. 19, 2019 -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company's Board of Directors has authorized a 1-for-700 reverse stock split of the...
NEW YORK, Dec. 03, 2019 -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that Dr. Jennifer Simpson, Ph.D., Chief Executive Officer and Ms. Barbra Keck, Chief...
NEW YORK, Oct. 22, 2019 -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent...
NEW YORK, Oct. 18, 2019 -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's Board of Directors has authorized a reverse stock split of the Company's...
NEW YORK, Oct. 08, 2019 -- Delcath Systems, Inc. ("Delcath," the "Company", "we", "our" or "us" (OTCQB: DCTH) will present at the MicroCap Rodeo. The conference will be held October 15-16, 2019 in Austin, Texas. Management will be available during the day on October...
NEW YORK, Sept. 23, 2019 -- Delcath Systems, Inc. ("Delcath," the "Company", "we", "our" or "us" (OTCQB: DCTH) will participate at the following upcoming investor conferences in New York: Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019,...
NEW YORK, Aug. 28, 2019 -- Delcath Systems, Inc. ("Delcath," the "Company", "we", "our" or "us" (OTCQB: DCTH) will present at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright, at 5:05pm on Tuesday, September 10, 2019. The...
Bringing total financial amount raised since July 2019 to $29.5M Cash runway past top-line results in 1H2020 with NDA submission anticipated by end of 2020 Recapitalization provides possible path to NASDAQ listing NEW YORK, Aug. 20, 2019 -- Delcath Systems, Inc....